Effect of Various Treatment Modalities on Dendritic Vial Ulcer

Status Recruiting

Clinical Trial Summary

Eye infection is a prevalent problem in primary care and remains a crucial healthcare concern. According to the American Academy of Ophthalmology (AAO), herpes simplex virus (HSV) keratitis (HSK) is the leading cause of infectious blindness worldwide . HSK is defined as a corneal inflammatory condition caused by the HSV infection . The global incidence of herpetic keratitis is estimated at 1.5 million per year, resulting in 40,000 new cases of severe visual impairment associated with corneal scarring and opacification . HSV type I (HSV-1) is by far the most predominant causative pathogen of eye infections]. HSV-1 is also known for causing orolabial herpes, HSV folliculitis, herpes gladiatorum, herpetic whitlow, and eczema herpeticum . HSV can be transferred to the eye by touching an active lesion and then the eye. The National Health and Nutrition Evaluation revealed a seroprevalence of HSV-1 in 53.9% of 14-49 year olds, and 90% of adults 50 years or older , indicating that the majority of the population has been exposed to this virus thus are at risk of developing HSK. In this study we evaluate the efficacy of different treatment modalities on viral keratitis HSK.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05313828
Study type	Observational
Source	Sohag University
Contact	Hany Mahmoud
Phone	00201024368111
Email	drhanymahmoud@gmail.com
Status	Recruiting
Phase
Start date	March 18, 2022
Completion date	July 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05705024` - Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells	Phase 2
Completed	`NCT02731638` - Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers	Phase 3
Completed	`NCT00324168` - Steroids for Corneal Ulcers Trial	Phase 4
Completed	`NCT04484402` - Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells	Phase 1/Phase 2
Completed	`NCT04820010` - Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3
Recruiting	`NCT02570321` - Cross-linking for Corneal Ulcers Treatment Trial	Phase 4
Completed	`NCT00386958` - A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers	Phase 2
Completed	`NCT04054817` - ACRO Biocornea Clinical Trial in Taiwan	N/A
Completed	`NCT00997035` - The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo	Phase 3
Completed	`NCT02277054` - Safety and Effectiveness of Collagen-phosphorylcholine Bioengineered Cornea in Patients Requiring Lamellar Keratoplasty	N/A
Recruiting	`NCT05255107` - Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers	Phase 2/Phase 3
Recruiting	`NCT05255016` - Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers	Phase 2/Phase 3
Completed	`NCT05891106` - AONDA Therapeutic Indication Study I
Terminated	`NCT00789646` - Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients	N/A
Not yet recruiting	`NCT05940376` - Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy
Completed	`NCT05200000` - Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis	Phase 1
Completed	`NCT01756456` - Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.	Phase 1/Phase 2
Active, not recruiting	`NCT01969786` - Village Integrated Eye Workers Trial	N/A
Completed	`NCT01794312` - Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer	Phase 3
Completed	`NCT04837534` - Improving the Follow up Rate for Pediatric Patients	N/A